Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multi-Center Treatment Study (COALL 08-09) to Improve the Survival of Children with Acute Lymphoblastic Leukemia on Behalf of the German Society of Pediatric Hematology and Oncology

NCT01228331 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT01228331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01228331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multi-Center Treatment Study (COALL 08-09) to Improve the Survival of Children with Acute Lymphoblastic Leukemia on Behalf of the German Society of Pediatric Hematology and Oncology
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2010
Completion date
November 20, 2024
Enrollment
745 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia